Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system
暂无分享,去创建一个
E. Bancalari | S. Ramos | C. Suguihara | D. Hehre | A. Martins | J. Camelo | E. Rosa
[1] U. Förstermann,et al. Nitric oxide synthases: regulation and function. , 2012, European heart journal.
[2] F. Murad,et al. Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells , 2011, Journal of Neuroscience Methods.
[3] K. Barrington,et al. Pulmonary hypertension and the asphyxiated newborn. , 2011, The Journal of pediatrics.
[4] M. Raizada,et al. ACE2, a promising therapeutic target for pulmonary hypertension , 2011, Current Opinion in Pharmacology.
[5] Josef M. Penninger,et al. Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters , 2010, Pharmacology & Therapeutics.
[6] A. Loeckinger,et al. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets , 2010, Critical care medicine.
[7] A. Ferreira,et al. Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis , 2008, Experimental physiology.
[8] E. Bancalari,et al. The Role of Angiotensin II Receptor-1 Blockade in the Hypoxic Pulmonary Vasoconstriction Response in Newborn Piglets , 2007, Neonatology.
[9] K. Nakayama,et al. Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.
[10] M. Frid,et al. Hypoxia-induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms Reviews , 2022 .
[11] D. Tibboel,et al. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase , 2006, Cell Biochemistry and Biophysics.
[12] K. Akimoto,et al. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats. , 2005, European journal of pharmacology.
[13] F. Traganos,et al. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[14] D. Pimentel,et al. Angiotensin II Differentially Regulates Interleukin-1-β-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression , 2004, Journal of Biological Chemistry.
[15] P. Puri,et al. Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. , 2004, Journal of pediatric surgery.
[16] J. Aschner,et al. Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[17] H. Thai,et al. Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.
[18] N. Garcia-Cairasco,et al. Immunohistochemical localization of myosin va in the adult rat brain , 2003, Neuroscience.
[19] R. Carey,et al. Angiotensin AT2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B2-Receptor–Null Mice , 2003, Hypertension.
[20] Thomas Walther,et al. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Hallman,et al. Nitrotyrosine and NO synthases in infants with respiratory failure: Influence of inhaled NO , 2003, Pediatric pulmonology.
[22] T. Malinski,et al. Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release , 2002, Hypertension.
[23] V. Campese,et al. Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension , 2002, Hypertension.
[24] T. Jeffery,et al. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. , 2001, Pharmacology & therapeutics.
[25] K. Hahnenkamp,et al. Selective iNOS Inhibition Prevents Hypotension in Septic Rats While Preserving Endothelium-Dependent Vasodilation , 2001, Anesthesia and analgesia.
[26] G. Laurent,et al. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. , 2000, American journal of respiratory and critical care medicine.
[27] J. Dubois-Randé,et al. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. , 2000, American journal of respiratory cell and molecular biology.
[28] L. Chimelli,et al. Microwave-stimulated recovery of myosin-V immunoreactivity from formalin-fixed, paraffin-embedded human CNS , 1999, Journal of Neuroscience Methods.
[29] G. Hosgood,et al. Detection and comparison of nitric oxide in clinically normal horses and those with naturally acquired small intestinal strangulation obstruction. , 1999, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[30] Nadia Smail,et al. Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages. , 1999, American journal of physiology. Cell physiology.
[31] M. Davies,et al. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809. , 1998, Surgery.
[32] G. Semenza,et al. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[33] Lan Zhao,et al. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung , 1996, British journal of pharmacology.
[34] W. Greenlee,et al. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. , 1996, Circulation.
[35] B. Lipworth,et al. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. , 1996, Chest.
[36] N. Morrell,et al. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. , 1995, The American journal of physiology.
[37] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[38] U. K. Laemmli,et al. Maturation of the head of bacteriophage T4. I. DNA packaging events. , 1973, Journal of molecular biology.
[39] U. K. Laemmli,et al. Maturation of the head of bacteriophage T4. II. Head-related, aberrant tau-particles. , 1973, Journal of molecular biology.
[40] C. Rosenfeld,et al. Vessel-Specific Regulation of Angiotensin II Receptor Subtypes During Ovine Development , 2005, Pediatric Research.